Skip to content

Long-term effectiveness and predictors of cognitive behavioral therapy for chronic dizziness

Long-term effectiveness and predictors of cognitive behavioral therapy for chronic dizziness - Long-term effectiveness and predictors of cognitive behavioral therapy for chronic dizziness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021150
Enrollment
100
Registered
2016-02-23
Start date
2016-02-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic dizziness (persistent postural-perceptual dizziness)

Interventions

Group program composed of vestibular rehabilitation and acceptance and commitment therapy: six weekly 2-hour sessions

Sponsors

Department of Psychiatry and Cognitive Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Outpatients with the chief complaint of chronic non-spinning vertigo, dizziness, or unsteadiness over three months, who has been consulting a neuro-otologist. 2) Fulfilling the diagnostic criteria for persistent postural-perceptual dizziness, with one or more of three exacerbation factors. 3) Sixteen or more of the total score of Dizziness Handicap Inventory.

Exclusion criteria

Exclusion criteria: 1) Vertigo or dizziness caused by central nervous or organic factors, assessed by a neuro-otologist. 2) Physical states disturbing cognitive behavioral therapy or vestibular rehabilitation. 3) need for hospitalization. 4) Obvious suicidal ideation or self-harm. 5) Previous history of schizophrenia or bipolar disorder. 6) Comorbid psychiatric disorders excluding anxiety disorders and somatic symptom and related disorders. 7) Receiving other structured psychotherapies (except supportive counseling). 8) Difficult of a routine visit. 9) During pregnancy or planning for pregnancy during the treatment period. 10) Other reasons inadequate for study participation.

Design outcomes

Primary

MeasureTime frame
Handicap due to dizziness (Dizziness Handicap Inventory) at 6 months after the treatment

Secondary

MeasureTime frame
Frequency of dizziness-related symptoms (Vertigo Symptom Scale-short form) Anxiety and depressive symptoms (Hospital Anxiety and Depression Scale) Somatic symptom (Somatic Symptom Scale-8) Health anxiety (Short Health Anxiety Inventory) Recovery process (Recovery Assessment Scale) Valued action (Valuing Questionnaire) Cognitive fusion (Cognitive Fusion Questionnaire) Quality of life (EQ-5D-5L) Alexithymia (Tronto Alexithymia Scale-20) Mindfulness (Mindfulness Attention Awareness Scale) Psychological flexibility (Acceptance and Action Questionnaire 2) Insomnia (Insomnia Severity Index) Clinical global impression Patient global impression

Countries

Japan

Contacts

Public ContactMasaki Kondo

Nagoya City University Graduate School of Medical Sciences Department of Psychiatry and Cognitive Behavioral Medicine

kondo-masaki@umin.ac.jp052-853-8271

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026